Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Cary Vance
AddedMar 31, 2024
UpdatedMay 31, 2026
Cary Vance

Cary Vance

Board Member, AVITA Medical

LinkedIn

Cary Vance's Career

AVITA Medical
AVITA Medical

Valencia, CA, US

Board Member· Board
Optiscan Biomedical
Optiscan Biomedical

Hayward, CA, US

Board Member· Board
PhotoniCare
PhotoniCare

Champaign, IL, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Cary Vance's Career

AVITA Medical
AVITA Medical
Public$300.4M1262020Valencia, CA, US
Board Member· Board

Leadership at AVITA Medical

Jeremy Curnock CookJeremy Curnock CookBoard Member
Fiona WoodFiona WoodFounder
Lou PanaccioLou PanaccioBoard Member
Jim CorbettJim CorbettBoard Member
Jan Stern ReedJan Stern ReedBoard Member

Similar to AVITA Medical

Aivita BiomedicalAivita BiomedicalIrvine, CA, USTherapies, Vaccinesest. 2016Aivita BiomedicalIrvine, CA, US · est. 2016

AIVITA Biomedical: Advancing curative and regenerative medicine programs.

Series A · $62.3M20
AvraAvraPalo Alto, CA, USAnti-Aging, Stem Cell Treatmentsest. 2010AvraPalo Alto, CA, US · est. 2010

Newregen Inc: A global biotech firm specializing in stem cell treatments and anti-aging solutions.

Seed · $150k6
Avacen MedicalAvacen MedicalSan Diego, CA, USMedical Devicesest. 2012Avacen MedicalSan Diego, CA, US · est. 2012

AVACEN offers non-invasive, painless treatments using cutting-edge technology to enhance body's thermal regulation.

Seed · $2M20
Avation MedicalAvation MedicalColumbus, OH, USHealthTech, Medical Devicesest. 2016Avation MedicalColumbus, OH, US · est. 2016

Avation Medical pioneers wearable nerve stimulation system platforms.

Series C · $34.9M125
Optiscan Biomedical
Optiscan Biomedical
Series E$165M751994Hayward, CA, US
Board Member· Board

Leadership at Optiscan Biomedical

NOAH J KROLOFFNOAH J KROLOFFBoard Member
Tara ButlerTara ButlerBoard Member
Paul A MieyalPaul A MieyalBoard Member
Kenneth AbramowitzKenneth AbramowitzBoard Member
Scott HalstedScott HalstedBoard Member
Daniel GoldbergerDaniel GoldbergerFounder

Similar to Optiscan Biomedical

GlumetricsGlumetricsIrvine, CA, USGlucose Monitors, Medical Devicesest. 2005GlumetricsIrvine, CA, US · est. 2005

GluMetrics Inc.: A US-based medical device company specializing in innovative glucose monitoring solutions.

Series A · $68.2M30
GlysensGlysensSan Diego, CA, USGlucose Monitorsest. 1998GlysensSan Diego, CA, US · est. 1998

San Diego-based GlySens, Inc. manufactures implantable glucose monitors for enhanced diabetes care across the US.

Series D · $34M75
DexcomDexcomSan Diego, CA, USGlucose Monitors, Medical Devicesest. 1999DexcomSan Diego, CA, US · est. 1999

Dexcom, Inc.: A San Diego-based medical device company specializing in continuous glucose monitoring systems for diabetics.

Public · $1.4B7.6k
GlucoVistaGlucoVistaFairfield Township, NJ, USMedical Devicesest. 2006GlucoVistaFairfield Township, NJ, US · est. 2006

GlucoVista Inc.: A US-based medical device company specializing in non-invasive blood glucose measuring equipment.

Seed · $2.7M3
PhotoniCare
PhotoniCare
Series A$18.2M222013Champaign, IL, US
Board Member· Board

Leadership at PhotoniCare

Ryan SheltonRyan SheltonCo-Founder
Stephen BoppartStephen BoppartCo-Founder
Ryan NolanRyan NolanCo-Founder

Similar to PhotoniCare

Diagnostic PhotonicsDiagnostic PhotonicsChicago, IL, USImaging, Medical Devicesest. 2008Diagnostic PhotonicsChicago, IL, US · est. 2008

Chicago-based Diagnostic Photonics creates real-time, advanced imaging tech for tissue evaluation.

Series B · $3M30
PhotopharmicsPhotopharmicsAmerican Fork, UT, USMedical Devicesest. 2011PhotopharmicsAmerican Fork, UT, US · est. 2011

PhotoPharmics: A clinical-stage medical device company innovating treatments for neurodegenerative disorders.

Series B · $31.9M7
LumedicaLumedicaDurham, NC, USImaging Technologiesest. 2014LumedicaDurham, NC, US · est. 2014

Lumedica: A tech startup innovating affordable, high-performance imaging for global disease detection.

Pre-Seed · $2.4M6
Phoenix ClinicalPhoenix ClinicalPleasanton, CA, USMedical Devicesest. 2014Phoenix ClinicalPleasanton, CA, US · est. 2014

Phoenix Clinical develops advanced retinal imaging devices, like ICON, to prevent blindness in pediatric patients.

Pre-Seed · $1M30

Cary Vance's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Cary Vance

Kent SavageKent SavageCo-Founder · PhotopharmicsTom ZajacTom ZajacBoard Member · Avant-garde HealthGeoffrey CrouseGeoffrey CrouseBoard Member · InvitaeJames HamiltonJames HamiltonCo-Founder · Xolve